ABM Industries Incorporated (NYSE:ABM) shares moved down -2.10% in last trading session and ended the day at $28.47. ABM Gross Margin is 10.00% and its has a return on assets of 3.40%. ABM Industries Incorporated (NYSE:ABM) quarterly performance is 4.63%.
ABM Industries (NYSE: ABM) declared a quarterly dividend of $0.165 per share, or $0.66 annualized. This is a 3.1% increase from the prior dividend of $0.16. The dividend will be payable on February 1, 2016, to stockholders of record on January 7, 2016, with an ex-dividend date of January 5, 2016.
Rite Aid Corporation (NYSE:RAD) ended the last trading day at $7.84. Company weekly volatility is calculated as 0.64% and price to cash ratio as 36.25. Rite Aid Corporation (NYSE:RAD) showed a weekly performance of -0.63%.
Rite Aid Corporation (NYSE: RAD) announced that it has established a record date of December 18, 2015, and a meeting date of February 4, 2016, for a special meeting of its stockholders to, among other things, consider and vote on a proposal to approve the previously announced Agreement and Plan of Merger, dated as of October 27, 2015 (the “Merger Agreement”), by and among Rite Aid, Walgreens Boots Alliance, Inc., a Delaware corporation (“WBA”), and Victoria Merger Sub, Inc., a Delaware corporation and a wholly owned direct subsidiary of WBA (“Victoria Merger Sub”), providing for the merger of Victoria Merger Sub with and into Rite Aid (the “Merger”), with Rite Aid surviving the Merger as a wholly owned direct subsidiary of WBA.
On 31 December, Oxford Immunotec Global PLC (NASDAQ:OXFD) shares moved down -3.69% and was closed at $11.50. OXFD EPS growth in last 5 year was -9.90%. Oxford Immunotec Global PLC (NASDAQ:OXFD) year to date (YTD) performance is -15.57%.
ON 22 December, Oxford Immunotec Global PLC (NASDAQ:OXFD), announced that it gained CE marking for the T-SPOT®.PRT test. The panel of reactive T cells (PRT) test assesses a solid organ transplant candidate’s T cell response to foreign tissue, referred to as alloreactivity.
Neothetics, Inc. (NASDAQ:NEOT) shares moved down -2.11% in last trading session and ended the day at $1.39. NEOT has a return on assets of -55.10%. Neothetics, Inc. (NASDAQ:NEOT) quarterly performance is -82.18%.
On December 21, 2015, Neothetics, Inc. (NASDAQ:NEOT) agreed to terms of separation of employment with Lincoln Krochmal, the Company’s Chief Medical Officer, effective January 21, 2016 (the “Separation Date”). In connection with his departure, and subject to entry into an effective release and waiver of claims from Dr. Krochmal, the Company has agreed to provide Dr. Krochmal (a) a cash payment equal to six months of base salary currently in effect, payable in accordance with the Company’s regular payroll cycle beginning on the first regular payday occurring 60 days following the Separation Date, and (b) payment of the premiums required to continue Dr. Krochmal’s group health coverage for a period of six months following the Separation Date.
Jaguar Animal Health, Inc. (NASDAQ:JAGX) caters to the Healthcare space. Its weekly performance is -6.25%. On the last day of trading company shares ended up at $2.25. Jaguar Animal Health, Inc. (NASDAQ:JAGX) distance from 50-day simple moving average (SMA50) is -0.01%.
Jaguar Animal Health, Inc. (NASDAQ:JAGX), announced that it has initiated a pivotal clinical field study to evaluate the safety and effectiveness of Canalevia™, the Company’s lead prescription drug product candidate for the treatment of acute diarrhea in dogs. Canalevia is a canine-specific formulation of crofelemer, a novel, first-in-class, anti-secretory active pharmaceutical ingredient isolated and purified from the Croton lechleri tree, which is sustainably harvested.
Leave a Reply